Eureka on the web
When you want the answer in the next five minutes.
The agent works the prompt against patents and technical literature, citing every source.
Run your analysis now →Filing growth compares 2021 (9 records) with 2024 (1) — a three-year span. 2024 is the most recent year we treat as complete: publication lags filing by roughly 18 months, so 2025 onwards are still filling in and any growth rate that ends there would understate the field. Top-5 share is the combined record count of the five largest assignees divided by all 60 records in scope (CR5), not by the ranked leaders only.
Soft-sensor bioprocessing inferential estimation sits at the intersection of process control and machine learning: patents that use a virtual or inferential sensor to estimate a biomass, metabolite or product state that a physical sensor cannot measure directly or cannot measure fast enough. The search string pulls records tagged with state-estimation, uncertainty-modelling or prediction-interval language alongside control-systems and AI classification codes, which is why the dataset skews toward general process-control assignees rather than bioreactor OEMs alone.
Sixty published records fall inside the window, spanning 2015 through the 2026 cut-off. Because publication trails filing by roughly eighteen months, the most recent one to two years understate real filing activity and should be read as provisional rather than declining.
Pick a task. Every answer cites the patents behind it.
Sixty records, thirty-five ranked assignees, and a technology mix that runs wider than bioprocessing alone — the numbers below set the boundaries for where claim space is dense and where it is not.
Filings rose from 2 in 2017 to a peak of 11 in 2018, then eased through the early 2020s; the drop from 9 records in 2021 to 1 in 2024 (-89%) is the clearest complete-year signal in the set, since 2025 and 2026 are still being filled in by the publication lag.
G05B (control and regulating systems) appears in 68.3% of the 60 records, more than double the next-largest class, G06N (AI-based computing) at 35.0%. C12M, the bioreactor and enzyme-apparatus class most specific to bioprocessing, appears in only 15.0% — most of the intellectual property here is written as generic estimation and control art that happens to be applicable to bioprocesses, rather than bioprocess-specific apparatus claims.
Shares are the percentage of the 60 records in scope. A patent can carry several IPC classes, so the shares add up to more than 100%.
This page is one run against one query. Ask Eureka your own question about soft-sensor bioprocessing inferential estimation and every answer comes back with the patent numbers behind it.
Try EurekaThe filing discloses a sensor error detection and compensation system with a sensor state estimation module that produces a confidence value for a physical sensor's output, then aggregates that reading with a virtual sensor's output and its own confidence value to produce a single blended estimate, with provision to replace the physical sensor's reading when confidence drops.Filed 2014-01-09 — illustrates the fused physical/virtual sensor architecture that recurs across this dataset's control-systems classifications.


| # | Publication no. | Patent title | Citations |
|---|---|---|---|
| 1 | US20090198350A1 | Robust adaptive model predictive controller with tuning to compensate for model mismatch | 291 |
| 2 | US20180262525A1 | Multi-modal, multi-disciplinary feature discovery to detect cyber threats in electric power grid | 140 |
| 3 | US6106785A | Polymerization process controller | 129 |
| 4 | US20110077783A1 | System and method for design and control of engineering systems utilizing component-level dynamic mathematica… | 128 |
| 5 | US6181975B1 | Industrial process surveillance system | 119 |
| 6 | US20140012791A1 | Systems and methods for sensor error detection and compensation | 106 |
| 7 | US20110230981A1 | Design and control of engineering systems utilizing component-level dynamic mathematical model with multiple-… | 54 |
| 8 | US20120221124A1 | Using autocorrelation to detect model mismatch in a process controller | 36 |
| 9 | EP2048562A1 | Method and device for providing at least one input sensor signal for a control and/or monitoring application … | 20 |
| 10 | US6440374B1 | Polymerization process controller | 20 |
Citation counts favour older filings inside any searched corpus; treat them as a signal of influence on later art, not of current commercial relevance.
Each row carries its publication number; clicking a row searches Eureka by that number.
When you want the answer in the next five minutes.
The agent works the prompt against patents and technical literature, citing every source.
Run your analysis now →When it has to run inside your own pipeline.
Patent search, landscape analysis and assignee resolution as MCP tools. Drop them into any agent framework, or call REST directly.
Browse MCP servers →Three patterns matter more than the raw counts: where the field is crowded, where citations concentrate, and where the recent-year data can and cannot be trusted.
The five most active filers already hold 61.7% of all 60 records in scope, rising to 88.3% across ten filers. That leaves a long tail of single- and double-filing entrants — mostly individual inventors and smaller specialists — competing for the remaining share.
The only fair year-over-year comparison available is 2021 to 2024, where filings fell 89%. Years after 2024 are not yet complete because of the roughly 18-month publication lag, so a reader should not treat 2025-2026's low counts as confirmation of further decline.
Records classified under G05B control-and-regulating-systems outnumber those under C12M bioreactor-and-enzyme apparatus by more than four to one. A filer targeting bioreactor-specific hardware integration is working in noticeably less crowded claim territory than one filing generic estimation methods.
The most-cited records in this set predate the bioprocessing framing entirely — model predictive control and industrial surveillance patents from the 1990s and 2000s. That is typical of citation counts inside a searched corpus: they reward age, not present-day relevance.
Eureka can read the same corpus for gaps instead of for coverage: under-claimed branches adjacent to soft-sensor bioprocessing inferential estimation, with the prior art for and against each one.
Thirty-five assignees make up the ranked field, with activity split between large process-control and industrial-automation companies and a scattering of individual inventors who co-file with each other.
The leading assignee holds 11 records against 5 at fifth place and 3 at tenth — a steep drop-off that marks this as a field with one clear leader rather than a tight cluster at the top.
Ten co-assignee pairs appear in the data, with one individual inventor recurring across the three strongest pairings at three joint filings each — a pattern more typical of an academic or consulting network than of corporate joint ventures.
Every one of the largest corporate assignees tracked for recent-year momentum shows zero filings in the latest year, including a -100% year-over-year drop for the leading filer. Given the publication lag, this is as likely to reflect filings still working through the pipeline as it is a genuine pause.
| Assignee | Recent year | YoY |
|---|---|---|
| Sartorius Stedim Data Analytics AB | 0 | -100% |
| General Electric Co | 0 | — |
| Honeywell International Inc | 0 | — |
| Fisher Rosemount Systems Inc | 0 | — |
| Siemens AG | 0 | — |
| RTX Corp | 0 | — |
| ROUILLAC NICHOLE SUZANNE | 0 | — |
| NARASIMHAN SRINIVASA | 0 | — |
The landscape points to a field where control-theory claims are dense and bioprocess-specific claims are comparatively open — the next step is testing a specific claim idea against that gap.
Before drafting, check a candidate claim against the G05B and G06N classifications directly, since these carry the bulk of prior art in this dataset.
Run a claim check in EurekaThe leading assignee's momentum has gone quiet in the most recent tracked year; watching for filings still moving through the publication lag matters before assuming the space has opened up.
Set up assignee monitoring in EurekaBioreactor-specific calibration and uncertainty-bounded prediction intervals show thin coverage relative to the core control-and-AI claims — worth a focused prior-art pull before committing R&D time.
Search white space in EurekaA soft sensor, also called a virtual or inferential sensor, is a model-based estimate of a process variable — biomass concentration, a metabolite level, or a product titre — that substitutes for or supplements a physical measurement that is slow, expensive, or unavailable in real time. In the patent literature this shows up as claims combining a state-estimation or uncertainty-modelling method with a control or AI classification. This dataset's search string specifically pulls records that pair soft-sensor language with state-estimation, biomass-estimate, or prediction-interval terms, which is why the results lean toward control-engineering assignees rather than bioreactor hardware makers alone.
The ranked field covers 35 assignees, with one filer well ahead of the rest at 11 records against 5 at fifth place and 3 at tenth. The five most active filers together account for 61.7% of all 60 records in scope, and the ten most active for 88.3%, which makes this a concentrated field with a long tail of smaller and individual filers behind the leaders. Recent-year momentum data, however, shows even the largest corporate filers with zero records in the latest tracked year, a pattern that likely reflects publication lag as much as any genuine pull-back.
The only reliable year-over-year comparison in the data is 2021 to 2024, where filings fell 89% from 9 records to 1. Filing peaked earlier, in 2018, at 11 records. Counts for 2025 and 2026 are still filling in because publication typically lags actual filing by around eighteen months, so those recent years should be read as incomplete rather than as evidence the field has gone quiet.
Control and regulating systems (IPC class G05B) appear in 68.3% of the 60 records, making it by far the dominant classification, followed by AI-based computing methods (G06N) at 35.0%. Bioreactor and enzyme apparatus (C12M), the class most specific to bioprocessing hardware, appears in only 15.0% of records. That gap suggests most patent activity in this space is written as general estimation and control methodology that is applicable to bioprocesses, rather than as bioprocess-specific equipment claims.
Given that generic control and AI classifications dominate the corpus while bioreactor-specific apparatus claims (C12M, 15.0% of records) are comparatively thin, the more open ground sits in claims that tie inferential estimation methods explicitly to bioreactor hardware, calibration routines, or uncertainty-bounded metabolite prediction. Sub-areas like hybrid mechanistic-machine-learning estimators for biomass and cross-scale transfer learning for soft sensors show limited dedicated coverage relative to the field's control-theory core. A freedom-to-operate search focused on these narrower combinations is more likely to surface open claim space than a search on soft-sensor estimation broadly.
Go past this page: query the whole soft-sensor bioprocessing inferential estimation corpus yourself, in your own scope.
Every answer comes back with patent numbers you can open.
Disclaimer. This page is generated from Patsnap Eureka data drawn from a limited snapshot of global patent and scientific-literature records, and is provided for general information and reference only.
Patent data carries inherent limitations: recent filings (typically the most recent 18–24 months) are under-counted due to standard publication lag; counts may be reported at either a patent-family or a patent-record basis and are not always directly comparable; classification, applicant-name, and citation data may contain errors, duplicates, or omissions; and the underlying search query defines and constrains the scope shown. As a result, the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing on this page constitutes an exhaustive prior-art, novelty, freedom-to-operate, or validity search, nor does it constitute legal, financial, investment, or professional advice, and it should not be relied upon as such. Any patent, commercial, or strategic decision should be verified independently and reviewed with qualified patent, legal, and domain professionals. Patsnap makes no warranties, express or implied, as to the accuracy, completeness, or fitness for any particular purpose of the information presented.
Machine translation. Assignee and organisation names originally recorded in Chinese, Japanese or Korean have been rendered into English by an AI translation step so that the tables stay readable. These renderings are best-effort and may not match a company's registered English name; the original name is what the underlying patent record carries, and it is what any Eureka query launched from this page uses.